Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 2,001–2,025 of 7,816 matching trials · page 81 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
LifeBio Memory Digital Reminiscence Platform NCT04769466 LifeBio Memory Runs in: United States · 1 site |
NA other |
COMPLETED | 234 | Benjamin Rose Institute on Aging OTHER |
2025-10-24 |
|
Neighborhood-based Physical and Social Activity for Older Black Caregivers and People Living With Dementia NCT05658328 SHARP - Physical and social activity Runs in: United States · 1 site |
NA other |
COMPLETED | 21 | Oregon Health and Science University OTHER |
2025-10-24 |
|
Treating Insomnia in Mild Cognitive Impairment NCT06687161 Transcranial Magnetic Stimulation (TMS) therapy; Cognitive behavior... Runs in: United States · 1 site |
NA other |
RECRUITING | 30 | Beth Israel Deaconess Medical Center OTHER |
2025-10-24 |
|
The Myelin Disorders Biorepository Project NCT03047369 Runs in: United States · 23 sites |
NA other |
RECRUITING | 12,000 | Children's Hospital of Philadelphia OTHER |
2025-10-23 |
|
Old SCHOOL Hip-Hop: Improve Alzheimer's Disease Knowledge NCT03284112 Old SCHOOL Hip-Hop; My Plate Runs in: United States · 1 site |
NA other |
COMPLETED | 2,244 | Columbia University OTHER |
2025-10-23 |
|
Support Via Technology: Living and Learning With Advancing Dementia-REVISED NCT06460012 STELLA-R Curriculum; Unrestricted Access; Limited Access Runs in: United States · 1 site |
NA other |
RECRUITING | 238 | Oregon Health and Science University OTHER |
2025-10-23 |
|
Stimulation of Cingulo-opercular Alertness Network NCT04817891 HD-tDCS Runs in: United States · 1 site |
NA other |
COMPLETED | 15 | University of Michigan OTHER |
2025-10-22 |
|
Preventing Loss of Independence Through Exercise in Community Living Centers NCT06972004 Preventing Loss of Independence through Exercise (PLIE) Runs in: United States · 1 site |
NA other |
ENROLLING_BY_INVITATION | 288 | VA Office of Research and Development OTHER_GOV |
2025-10-22 |
|
Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder NCT03513549 Loxapine 10 MG Runs in: United States · 1 site |
NA other |
SUSPENDED | 10,000 | Alexza Pharmaceuticals, Inc. UNKNOWN |
2025-10-21 |
|
Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease NCT04120493 intra-striatal rAAV5-miHTT; Imitation (sham) surgery Runs in: United States · 12 sites |
PHASE1|PHASE2 gene-therapy |
ACTIVE_NOT_RECRUITING | 43 | UniQure Biopharma B.V. INDUSTRY |
2025-10-21 |
|
SNIFF - Combo INI+EMPA Trial NCT05081219 Insulin (Humulin® R U-100); Empagliflozin 10 MG; Aptar Pharma CPS I... Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 47 | Wake Forest University Health Sciences OTHER |
2025-10-21 |
|
STRIDE: Stress Reduction in Dementia Caregivers NCT05732038 Healthy Minds Program (HMP); Wellness App (WA) Runs in: United States · 1 site |
NA other |
COMPLETED | 93 | Massachusetts General Hospital OTHER |
2025-10-21 |
|
Gene Therapy for APOE4 Homozygote of Alzheimer's Disease NCT03634007 LX1001 Runs in: United States · 4 sites |
PHASE1|PHASE2 gene-therapy |
COMPLETED | 15 | Lexeo Therapeutics INDUSTRY |
2025-10-20 |
|
Neurofeedback to Aid Vets' Memory NCT04446481 Neurofeedback Runs in: United States · 1 site |
NA other |
COMPLETED | 4 | VA Office of Research and Development OTHER_GOV |
2025-10-20 |
|
Memory Training and Neural Plasticity NCT05380739 Working Memory Training Runs in: United States · 1 site |
NA other |
TERMINATED | 24 | University of Michigan OTHER |
2025-10-20 |
|
A Pilot Randomized Controlled Trial: CoINTEGRATE NCT05732285 CRT; CBT; Modifiable lifestyle factors; Usual care Psychoeducation Runs in: United States · 1 site |
NA other |
COMPLETED | 15 | University of Michigan OTHER |
2025-10-20 |
|
Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease NCT04795466 Canakinumab; Placebo Runs in: Finland; Iceland; United Kingdom; United States · 10 sites |
PHASE2 anti-inflammatory |
TERMINATED | 34 | Novartis Pharmaceuticals INDUSTRY |
2025-10-16 |
|
Registry for CADASIL NCT05567744 Registry Runs in: United States · 1 site |
NA other |
RECRUITING | 2,500 | University of Wisconsin, Madison OTHER |
2025-10-16 |
|
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type NCT02446132 AVP-786 Runs in: Bulgaria; Canada; Czechia; France; Hungary; Italy; Poland... · 227 sites |
PHASE3 other |
TERMINATED | 1,197 | Otsuka Pharmaceutical Development & Commercialization, Inc. INDUSTRY |
2025-10-15 |
|
Treating Primary Progressive Aphasia (PPA) Using High-definition tDCS NCT04046991 high-definition transcranial direct current stimulation; modified c... Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 76 | University of Pennsylvania OTHER |
2025-10-15 |
|
Person-Environment Fit for Persons With Dementia NCT05722743 Harmony at HOME; National Institute on Aging Program Runs in: United States · 1 site |
NA other |
COMPLETED | 84 | Elizabeth K Rhodus OTHER |
2025-10-15 |
|
Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease NCT05771428 ABBV-552; Placebo for ABBV-552 Runs in: Australia; Germany; Japan; New Zealand; Spain; United Kin... · 64 sites |
PHASE2 other |
COMPLETED | 263 | AbbVie INDUSTRY |
2025-10-15 |
|
Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living NCT05956665 Shed-MEDS deprescribing intervention Runs in: United States · 2 sites |
NA other |
COMPLETED | 18 | Vanderbilt University OTHER |
2025-10-15 |
|
bpMedManage: Digital Technology to Support Adherence to Hypertension Medications NCT06307574 bpMedManage Runs in: United States · 2 sites |
NA other |
RECRUITING | 100 | University of Arizona OTHER |
2025-10-15 |
|
Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG) NCT04033510 Standard of Care Interventions to convert patient from atrial fibri... Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 600 | David Brunk, PA-C, MMS OTHER |
2025-10-14 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial